Dr. Noa Kirshenboim, PhD
About Dr. Noa Kirshenboim, PhD
Dr. Noa Kirshenboim is the Head of Clinical Operation at Bristol Myers Squibb in Israel, with extensive experience in managing clinical trials across multiple continents and phases.
Current Position at Bristol Myers Squibb
Dr. Noa Kirshenboim currently holds the position of Head of Clinical Operation at BMS Israel. In this role, she is responsible for overseeing the clinical operations within the Israeli branch of Bristol Myers Squibb. Her duties include managing clinical trials, ensuring regulatory compliance, and leading cross-functional teams to achieve company objectives. Her extensive experience in clinical research and operations plays a crucial role in advancing BMS's clinical programs in Israel.
Previous Role at Covance
Prior to her current position, Dr. Noa Kirshenboim worked at Covance as a Senior Global Project Manager from 2019 to 2020. During her tenure, she was responsible for managing global clinical projects, ensuring timely delivery and adherence to budget constraints. Her role required coordination with international teams, problem-solving, and strategic planning to drive successful project outcomes.
Experience at PolyPid
From 2018 to 2019, Dr. Noa Kirshenboim served as the VP of Clinical Operations at PolyPid. In this capacity, she was tasked with leading clinical development activities and managing various operational aspects of clinical trials. Her nine-month engagement saw her implement innovative strategies and oversee multiple projects aimed at progressing the company's clinical pipeline.
Academic Background
Dr. Noa Kirshenboim holds a PhD in Molecular Biology from Tel Aviv University, which she earned between 2003 and 2007. Prior to that, she completed her MSc in Genetics at the same institution, studying from 2001 to 2003. Her strong academic background in the biological sciences has laid a solid foundation for her career in clinical research and operations management.
Extensive Clinical Research Experience
Dr. Noa Kirshenboim has extensive experience in leading clinical trials across multiple continents, including the US, Europe, and the Asia Pacific region. She has managed clinical trials from Phase I to Phase IV, working with various Contract Research Organization (CRO) operating models. Her strategic thinking, operational skills, and proactive approach to problem-solving have been crucial in her successful career in clinical research.